Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

U.S. Genomics Expands its Efforts With New VP

Published: Friday, September 30, 2005
Last Updated: Friday, September 30, 2005
Bookmark and Share
U.S. Genomics Names Duncan Whitney as Vice President of Research and Development.

U.S. Genomics has announced that Dr. Duncan Whitney joined the Company's management team as Vice President of Research and Development.

Dr. Whitney will spearhead existing efforts in the Company's single molecule technology, which directly detects and quantitates individual molecules of miRNA, DNA, RNA, and proteins without the need for amplification.

“Duncan brings significant scientific and product development experience to the Company,” said John J. Canepa, acting Chief Executive Officer of U.S. Genomics.

“Duncan will play a key role in the development of additional applications for the Trilogy 2020 platform as we accelerate our commercialization efforts.”

“Duncan's success in driving research and development at EXACT Sciences Corporation and other emerging life science companies makes him an excellent addition to our team.”

Prior to joining U.S. Genomics, Dr. Whitney served as Vice President of Technology for EXACT Sciences developing DNA diagnostic assays for cancer screening.

Previously, he held senior management positions at Molecular Geodesics, PerSeptive Biosystems (now Applied Biosystems,Inc.), and Polaroid Corporation.

Dr. Whitney earned his PhD in Polymer Sciences from the Massachusetts Institute of Technology and a B.S. in Chemistry fromColby College.

“U.S. Genomics' technology has the potential to revolutionize how scientists perform life science research and I look forward to utilizing my experience at U.S. Genomics to make this technology widely available,” said Dr. Whitney.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

U.S. Genomics Announces Recipient of Outstanding Investigator in Single Molecule Biology Award
Dr. James A. Spudich will be presented the award at the 50th Annual Meeting of the Biophysical Society.
Tuesday, February 21, 2006
U.S. Genomics Announces New Chief Executive Officer
John J. Canepa has been promoted to President, CEO and member of the Board of Directors.
Friday, December 16, 2005
NSF Awards U.S. Genomics a $500K Phase II-B SBIR Grant
The $500,000 grant is earmarked for development of a commercial platform that uses the Company's rapid DNA analysis and genomic mapping technologies.
Friday, October 07, 2005
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Sensor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!